Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595472 | SCV000707154 | uncertain significance | not provided | 2017-03-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001242510 | SCV001415603 | uncertain significance | Bifunctional peroxisomal enzyme deficiency; Perrault syndrome | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with threonine at codon 93 of the HSD17B4 protein (p.Ile93Thr). The isoleucine residue is highly conserved and there is a moderate physicochemical difference between isoleucine and threonine. This variant is present in population databases (rs544455125, ExAC 0.07%). This variant has not been reported in the literature in individuals affected with HSD17B4-related conditions. ClinVar contains an entry for this variant (Variation ID: 500977). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001834901 | SCV002075397 | uncertain significance | Bifunctional peroxisomal enzyme deficiency | 2019-10-28 | no assertion criteria provided | clinical testing |